Completed
Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
NCT00320658
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- Center for Immunization Research, Johns Hopkins University, Bloomberg School of Public Health Washington D.C., District of Columbia, United States